Cleerly LABS vs FFRct
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 75/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Cleerly LABS offers comprehensive anatomical analysis of coronary plaque and stenosis, focusing on disease characterization and progression tracking. In contrast, HeartFlow FFRct specializes in assessing the physiological impact of blockages by calculating fractional flow reserve (FFRct) values to determine blood flow significance. While both leverage CCTA data for coronary artery disease management, Cleerly provides detailed morphological insights, whereas HeartFlow delivers functional assessment to guide revascularization decisions.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
Cleerly LABS focuses on comprehensive analysis of coronary CT angiography (CCTA) to detect, quantify, and characterize atherosclerosis and stenosis, including plaque volume and type. HeartFlow FFRct analyzes CCTA scans to create personalized 3D models of coronary arteries, assessing blood flow and identifying areas of narrowing using FFRct values to aid in diagnosing coronary artery disease.
Cleerly LABS aids in personalized heart disease risk assessment and tracking disease progression over time by providing detailed plaque assessment and stenosis detection. HeartFlow FFRct helps guide treatment strategies and revascularization decisions by analyzing blood flow and identifying areas of narrowing to diagnose coronary artery disease.
Cleerly LABS offers ischemia detection with its Cleerly ISCHEMIA module. HeartFlow FFRct analyzes blood flow and identifies areas of narrowing (FFRct values) which inherently aids in assessing the physiological significance of blockages, but does not explicitly mention a separate 'ischemia module'.
More Comparisons
Backers
Who funded each tool's parent company.